KYMR
Price
$30.13
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
1.96B
70 days until earnings call
RIGL
Price
$19.19
Change
-$1.75 (-8.36%)
Updated
May 23, 10:30 AM (EDT)
Capitalization
352.62M
Interact to see
Advertisement

KYMR vs RIGL

Header iconKYMR vs RIGL Comparison
Open Charts KYMR vs RIGLBanner chart's image
Kymera Therapeutics
Price$30.13
Change-$0.00 (-0.00%)
Volume$572.98K
Capitalization1.96B
Rigel Pharmaceuticals
Price$19.19
Change-$1.75 (-8.36%)
Volume$8.14K
Capitalization352.62M
KYMR vs RIGL Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. RIGL commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and RIGL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (KYMR: $30.13 vs. RIGL: $20.94)
Brand notoriety: KYMR and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 82% vs. RIGL: 1%
Market capitalization -- KYMR: $1.96B vs. RIGL: $352.62M
KYMR [@Biotechnology] is valued at $1.96B. RIGL’s [@Biotechnology] market capitalization is $352.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, RIGL is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 5 TA indicator(s) are bullish while RIGL’s TA Score has 7 bullish TA indicator(s).

  • KYMR’s TA Score: 5 bullish, 5 bearish.
  • RIGL’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +0.37% price change this week, while RIGL (@Biotechnology) price change was +6.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.00%. For the same industry, the average monthly price growth was +5.57%, and the average quarterly price growth was -1.69%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

RIGL is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+3.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($1.97B) has a higher market cap than RIGL($353M). RIGL YTD gains are higher at: 24.495 vs. KYMR (-25.106). RIGL has higher annual earnings (EBITDA): 48.5M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. RIGL (77.1M). RIGL has less debt than KYMR: RIGL (61.1M) vs KYMR (86.3M). RIGL has higher revenues than KYMR: RIGL (203M) vs KYMR (58.9M).
KYMRRIGLKYMR / RIGL
Capitalization1.97B353M557%
EBITDA-232.67M48.5M-480%
Gain YTD-25.10624.495-102%
P/E RatioN/A9.44-
Revenue58.9M203M29%
Total Cash463M77.1M601%
Total Debt86.3M61.1M141%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRRIGL
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
72%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NEFFX62.230.13
+0.21%
American Funds New Economy F2
NSDVX20.40N/A
N/A
North Star Dividend I
PICOX45.74N/A
N/A
Putnam International Capital Opp R6
PCBSX15.05N/A
N/A
BlackRock Tactical Opportunities Service
HFDYX18.71N/A
N/A
Hartford Schroders US MidCap Opps Y

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
N/A
CCCC - KYMR
64%
Loosely correlated
N/A
RCKT - KYMR
58%
Loosely correlated
N/A
RVMD - KYMR
57%
Loosely correlated
+0.15%
CGON - KYMR
56%
Loosely correlated
-1.75%
IMNM - KYMR
56%
Loosely correlated
+6.82%
More